<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="2516">
  <stage>Registered</stage>
  <submitdate>23/09/2009</submitdate>
  <approvaldate>23/09/2009</approvaldate>
  <nctid>NCT00987389</nctid>
  <trial_identification>
    <studytitle>Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis</studytitle>
    <scientifictitle>Plasma Exchange and Glucocorticoid Dosing in the Treatment of Anti-neutrophil Cytoplasm Antibody Associated Vasculitis: an International Randomized Controlled Trial</scientifictitle>
    <utrn />
    <trialacronym>PEXIVAS</trialacronym>
    <secondaryid>R01FD00351604</secondaryid>
    <secondaryid>PEXIVAS</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Granulomatosis With Polyangiitis (Wegener's) (GPA)</healthcondition>
    <healthcondition>Microscopic Polyangiitis (MPA)</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Diseases of the vasculature and circulation including the lymphatic system</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Other inflammatory or immune system disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Autoimmune diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: surgery - Plasma Exchange
Treatment: drugs - Glucocorticoids

Other: No Plasma Exchange - Participants in this arm do not undergo plasma exchange

Experimental: Plasma Exchange - 


Treatment: surgery: Plasma Exchange
Plasma exchange is a procedure whereby blood is taken from the body and separated by a machine into blood cells and plasma, which is the liquid part of blood. The plasma is discarded and the blood cells are returned to the body with a plasma substitute.

Treatment: drugs: Glucocorticoids
During the study, a standard glucocorticoids dose regimen will be compared to a reduced glucocorticoids dose regimen. All subjects' patients will receive the same glucocorticoids dose for the first two weeks then the dose will decrease following either a standard regimen or a reduced regimen.

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: surgery</interventioncode>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>All-cause mortality</outcome>
      <timepoint>2 years after the final subject is enrolled</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>End-stage renal disease</outcome>
      <timepoint>2 years after final subject is enrolled</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Sustained remission - Remission that occurs before 6 months, and lasts without a first relapse until at least 12 months after randomization</outcome>
      <timepoint>2 years after the final subject is enrolled</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Rate of serious infections</outcome>
      <timepoint>12 months after first subject enrolled and at study end</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Health-related quality of life using the SF-36 Physical Composite, Mental Composite and EQ-5D Index Score</outcome>
      <timepoint>12 months after study enrollment is completed</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria> New or previous clinical diagnosis of granulomatosis with polyangiitis or microscopic
        polyangiitis consistent with the Chapel-Hill consensus definitions

        AND

         Positive test for proteinase 3-ANCA or myeloperoxidase-ANCA

        AND

          -  Severe vasculitis defined by at least one of the following:

               1. Renal involvement with both:

                    -  Renal biopsy demonstrating focal necrotizing glomerulonephritis or active
                       urine sediment characterized by glomerular haematuria or red cell casts and
                       proteinuria

                  AND

                    -  eGFR &lt;50 ml/min/1.73 m2

               2. Pulmonary hemorrhage due to active vasculitis defined by:

                    -  A compatible chest x-ray or CT scan (diffuse pulmonary infiltrates)

                  AND

                    -  The absence of an alternative explanation for all pulmonary infiltrates
                       (e.g. volume overload or pulmonary infection)

                  AND

               3. At least one of the following:

                    -  Evidence of alveolar hemorrhage on bronchoscopic examination or increasingly
                       bloody returns with bronchoalveolar lavage

                    -  Observed hemoptysis

                    -  Unexplained anemia (&lt;10 g/dL) or documented drop in hemoglobin &gt;1 g/dL)

                    -  Increased diffusing capacity of carbon dioxide

          -  Provision of informed consent by patient or a surrogate decision maker</inclusivecriteria>
    <inclusiveminage>15</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  A diagnosis of vasculitis other than granulomatosis with polyangiitis or microscopic
             polyangiitis

          -  Positive anti-glomerular basement membrane antibody test or renal biopsy demonstrating
             linear glomerular immunoglobulin deposition

          -  Receipt of dialysis for &gt;21 days immediately prior to randomization or prior renal
             transplant

          -  Age &lt;15 years

          -  Pregnancy

          -  Inability or unwillingness to comply with birth control/abstinence

          -  Treatment with &gt;1 IV dose of cyclophosphamide and/or &gt;14 days of oral cyclophosphamide
             and/or &gt;14 days of prednisone/prednisolone (&gt;30 mg/day) and/or &gt;1 dose of rituximab
             within the 28 days immediately prior to randomization

          -  A comorbidity that, in the opinion of the investigator, precludes the use of
             cyclophosphamide, glucocorticoids, or plasma exchange or absolutely mandates the use
             of plasma exchange</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Factorial</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate />
    <actualstartdate>1/05/2010</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>704</actualsamplesize>
    <recruitmentstatus>Active, not recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>1/04/2018</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>ACT,NSW,QLD,SA,TAS,VIC,WA</recruitmentstate>
    <hospital>Canberra Hospital - Garran</hospital>
    <hospital>Concord Repatriation General Hospital - Concord</hospital>
    <hospital>John Hunter Hospital, - New Lambton Heights</hospital>
    <hospital>Prince of Wales Hospital - Randwick</hospital>
    <hospital>Royal North Shore Hospital - St. Leonards</hospital>
    <hospital>Royal Brisbane and Women's Hospital - Herston</hospital>
    <hospital>Nambour Hospital - Nambour</hospital>
    <hospital>Princess Alexandra Hospital - Woolloongabba</hospital>
    <hospital>Flinders Medical Centre, - Adelaide</hospital>
    <hospital>Royal Adelaide Hospital - Adelaide</hospital>
    <hospital>Royal Hobart Hospital - Hobart</hospital>
    <hospital>Monash Medical Centre - Clayton</hospital>
    <hospital>St Vincent's Hospital - Fitzroy</hospital>
    <hospital>The Geelong Hospital - Geelong</hospital>
    <hospital>Austin Hospital - Heidelberg</hospital>
    <hospital>The Royal Melbourne Hospital - Parkville</hospital>
    <hospital>Fremantle Hospital, - Fremantle,</hospital>
    <hospital>Gold Coast Hospital - Southport</hospital>
    <postcode> - Garran</postcode>
    <postcode> - Concord</postcode>
    <postcode> - New Lambton Heights</postcode>
    <postcode> - Randwick</postcode>
    <postcode> - St. Leonards</postcode>
    <postcode> - Herston</postcode>
    <postcode> - Nambour</postcode>
    <postcode> - Woolloongabba</postcode>
    <postcode> - Adelaide</postcode>
    <postcode> - Hobart</postcode>
    <postcode> - Clayton</postcode>
    <postcode> - Fitzroy</postcode>
    <postcode> - Geelong</postcode>
    <postcode> - Heidelberg</postcode>
    <postcode> - Parkville</postcode>
    <postcode> - Fremantle,</postcode>
    <postcode> - Southport</postcode>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>California</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Massachusetts</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Minnesota</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Missouri</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>North Carolina</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Ohio</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Pennsylvania</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Virginia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Belgium</country>
      <state>Leuven</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Alberta</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>British Columbia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Ontario</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Canada</country>
      <state>Quebec</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Czechia</country>
      <state>Prague</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Denmark</country>
      <state>Aarhus</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Denmark</country>
      <state>Copenhagen</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Denmark</country>
      <state>Holstebro</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Boulogne-sur-Mer</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Brest</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Caen</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Clermont Ferrand</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Colmar</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>D'Angers</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Grenoble</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Metz</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Mulhouse</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Paris</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Pringy</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Toulouse</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Tours</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>France</country>
      <state>Valenciennes</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Greece</country>
      <state>Thessaloniki</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Brescia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Italy</country>
      <state>Parma</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Japan</country>
      <state>Ibaraki</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Japan</country>
      <state>Kyoto</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Japan</country>
      <state>Miyazaki</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Japan</country>
      <state>Osaka</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Japan</country>
      <state>Tokyo</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Mexico</country>
      <state>Mexico City</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Dunedin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Hamilton</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Norway</country>
      <state>Tromsoe</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Norway</country>
      <state>Trondheim</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Sweden</country>
      <state>Linkoping</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Sweden</country>
      <state>Malmo</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Sweden</country>
      <state>Stockholm</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Scotland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Aberdeen</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Birmingham</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Brighton</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Cambridge</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Canterbury</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Coventry</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Edinburgh</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Exeter</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Leeds</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Liverpool</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>London</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Manchester</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Newcastle</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Oxford</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Preston</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>Reading</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>University of Pennsylvania</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Government body</othercollaboratortype>
      <othercollaboratorname>National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>University of Birmingham</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Cambridge University Hospitals NHS Foundation Trust</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to determine whether plasma exchange as well as
      immunosuppressive therapy are effective in reducing death and end-stage renal disease (ESRD).
      The trial will also study whether a reduced cumulative dosing regimen of glucocorticoids is
      as effective as a standard disease regimen.

      The FDA-OOPD is one of the funding sources for this study.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00987389</trialwebsite>
    <publication>Walsh M, Merkel PA, Peh CA, Szpirt W, Guillevin L, Pusey CD, De Zoysa J, Ives N, Clark WF, Quillen K, Winters JL, Wheatley K, Jayne D; PEXIVAS Investigators. Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial. Trials. 2013 Mar 14;14:73. doi: 10.1186/1745-6215-14-73.
</publication>
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>David Jayne, MD</name>
      <address>Cambridge University Hospitals NHS Foundation Trust</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>